ROYAL OAK, Mich.--(BUSINESS WIRE)--Agree Realty Corporation (NYSE: ADC) (the “Company”) today announced a summary of its investment activity in 2025, introduced investment guidance for 2026, and p

Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors

07:00am, Monday, 05'th Jan 2026

CR-001 IND cleared by U.S. FDA; Phase 1/2 ASCEND global clinical trial to evaluate CR-001 in first-line and previously treated patients on track to initiate in first quarter of 2026, with proof-of-con

ADC Therapeutics Announces New Employee Inducement Grant

04:05pm, Friday, 02'nd Jan 2026

LAUSANNE, Switzerland, Jan. 2, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that

If I Were To Retire Today, This Is The 20-Stock Portfolio I'd Own

07:30am, Friday, 02'nd Jan 2026

I present a 20-stock model retirement portfolio targeting a balanced 5.6% yield, emphasizing both income and dividend growth. My approach avoids "sucker yields" by focusing on quality, sustainable pay

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

10:00am, Thursday, 01'st Jan 2026

NEW YORK, Jan. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC Therapeutics" or the "Company") (NYSE: ADCT). Such investors are adv

2 Long-Term Winners I'm Looking To Buy In 2026

07:15am, Thursday, 01'st Jan 2026

Agree Realty and Build-A-Bear Workshop are high-quality, long-term holdings but currently trade at or above fair value. I target ADC as a nibble under $70, a buy under $65, and a strong buy under $60,

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

12:50pm, Tuesday, 30'th Dec 2025

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC Therapeutics” or the “Company”) (NYSE: ADCT). Such in

Agree Realty (NYSE:ADC) Director John Rakolta, Jr. Purchases 15,000 Shares of Stock

05:16am, Tuesday, 30'th Dec 2025

Agree Realty Corporation (NYSE: ADC - Get Free Report) Director John Rakolta, Jr. acquired 15,000 shares of Agree Realty stock in a transaction on Wednesday, December 24th. The stock was purchased at

The Smartest Dividend Stocks to Buy With $1,000 Right Now

08:15pm, Sunday, 28'th Dec 2025

ExxonMobil has increased its dividend payment for 43 years in a row. Agree Realty has grown its dividend at a 5.3% compound annual rate over the last 10 years.

Boomers Are Buying These 5 High-Quality Monthly Dividend Stocks Hand Over Fist

08:12am, Wednesday, 24'th Dec 2025

While reaching retirement age can be both a blessing and a curse, relying on the U.S.

Agree Realty Corporation $ADC Shares Acquired by Exchange Traded Concepts LLC

04:09am, Wednesday, 24'th Dec 2025

Exchange Traded Concepts LLC boosted its stake in Agree Realty Corporation (NYSE: ADC) by 33.2% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Excha

Agree Realty: A Monthly Dividend REIT Worth Accumulating

03:08am, Wednesday, 24'th Dec 2025

Agree Realty Corporation offers a high-quality, diversified net lease retail REIT portfolio, with peer-leading investment-grade tenant concentration and robust lease terms. ADC trades below intrinsic

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by